Neogen (NEOG) Stock Forecast, Price Target & Predictions
NEOG Stock Forecast
Neogen stock forecast is as follows: an average price target of $17.50 (represents a 52.17% upside from NEOG’s last price of $11.50) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
NEOG Price Target
The average price target for Neogen (NEOG) is $17.50 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $17.50 to $17.50. This represents a potential 52.17% upside from NEOG's last price of $11.50.
NEOG Analyst Ratings
According to 3 Wall Street analysts, Neogen's rating consensus is 'Buy'. The analyst rating breakdown for NEOG stock is 0 'Strong Buy' (0.00%), 2 'Buy' (66.67%), 1 'Hold' (33.33%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Neogen Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 06, 2024 | David Westenberg | Piper Sandler | $17.50 | $16.15 | 8.36% | 52.17% |
| Dec 14, 2022 | David Westenberg | Piper Sandler | $17.00 | $15.35 | 10.75% | 47.83% |
| Oct 09, 2022 | David Westenberg | Piper Sandler | $14.00 | $12.68 | 10.41% | 21.74% |
The latest Neogen stock forecast, released on Aug 06, 2024 by David Westenberg from Piper Sandler, set a price target of $17.50, which represents a 8.36% increase from the stock price at the time of the forecast ($16.15), and a 52.17% increase from NEOG last price ($11.50).
Neogen Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 1 |
| Avg Price Target | - | - | $17.50 |
| Last Closing Price | $11.50 | $11.50 | $11.50 |
| Upside/Downside | -100.00% | -100.00% | 52.17% |
In the current month, the average price target of Neogen stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Neogen's last price of $11.50. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Dec 19, 2024 | Guggenheim | Buy | Initialise | |
| Aug 06, 2024 | Piper Sandler | Neutral | Neutral | Hold |
| Oct 10, 2023 | William Blair | Outperform | Outperform | Hold |
| Dec 14, 2022 | Piper Sandler | Neutral | Neutral | Hold |
| Nov 22, 2022 | William Blair | Outperform | Upgrade | |
| Oct 09, 2022 | Piper Sandler | Neutral | Neutral | Hold |
Neogen's last stock rating was published by Guggenheim on Dec 19, 2024. The company Initialise its NEOG rating from "null" to "Buy".
Neogen Financial Forecast
Neogen Revenue Forecast
| May 27 | Mar 27 | Nov 26 | Aug 26 | May 26 | Mar 26 | Nov 25 | Aug 25 | May 25 | Mar 25 | Nov 24 | Aug 24 | May 24 | Mar 24 | Nov 23 | Aug 23 | May 23 | Mar 23 | Dec 22 | Aug 22 | May 22 | Mar 22 | Dec 21 | Aug 21 | May 21 | Mar 21 | Dec 20 | Aug 20 | May 20 | Mar 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $228.99M | $241.81M | - | - | $132.35M | $140.09M | - | - | $128.31M | $127.42M | - | - | $109.33M | $109.07M | - |
| Avg Forecast | $272.35M | $255.25M | $249.90M | $238.60M | $253.69M | $240.64M | $239.48M | $226.40M | $241.91M | $229.13M | $228.33M | $215.05M | $225.83M | $229.61M | $232.85M | $231.10M | $227.72M | $218.87M | $142.99M | $135.75M | $138.37M | $130.00M | $129.06M | $121.20M | $122.32M | $106.73M | $115.16M | $105.79M | $112.15M | $102.42M |
| High Forecast | $280.31M | $262.71M | $257.20M | $245.57M | $261.10M | $247.67M | $246.48M | $233.02M | $248.98M | $238.59M | $228.68M | $215.05M | $225.83M | $229.81M | $236.20M | $237.85M | $234.38M | $225.26M | $171.59M | $137.14M | $139.78M | $131.33M | $130.38M | $122.44M | $123.57M | $107.82M | $116.34M | $106.87M | $113.30M | $103.46M |
| Low Forecast | $265.79M | $249.10M | $243.88M | $232.85M | $247.58M | $234.85M | $233.72M | $220.95M | $236.09M | $222.25M | $227.75M | $215.05M | $225.83M | $229.40M | $229.75M | $225.54M | $222.24M | $213.60M | $114.39M | $134.67M | $137.27M | $128.97M | $128.04M | $120.24M | $121.35M | $105.88M | $114.25M | $104.95M | $111.26M | $101.60M |
| # Analysts | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 3 | 2 | 2 | 1 | 17 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 5 | 5 | 5 | 9 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.99% | 1.06% | - | - | 0.97% | 1.01% | - | - | 1.06% | 1.04% | - | - | 1.03% | 0.97% | - |
Neogen's average Quarter revenue forecast for Nov 23 based on 3 analysts is $232.85M, with a low forecast of $229.75M, and a high forecast of $236.20M. NEOG's average Quarter revenue forecast represents a 1.69% increase compared to the company's last Quarter revenue of $228.99M (Aug 23).
Neogen EBITDA Forecast
| May 27 | Mar 27 | Nov 26 | Aug 26 | May 26 | Mar 26 | Nov 25 | Aug 25 | May 25 | Mar 25 | Nov 24 | Aug 24 | May 24 | Mar 24 | Nov 23 | Aug 23 | May 23 | Mar 23 | Dec 22 | Aug 22 | May 22 | Mar 22 | Dec 21 | Aug 21 | May 21 | Mar 21 | Dec 20 | Aug 20 | May 20 | Mar 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 3 | 2 | 2 | 1 | 17 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 5 | 5 | 5 | 9 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $19.14M | $23.43M | - | - | $6.06M | $18.03M | - | - | $27.41M | $26.08M | - | - | $24.53M | $26.03M | - |
| Avg Forecast | $52.63M | $49.33M | $48.29M | $46.11M | $49.02M | $46.50M | $46.28M | $43.75M | $46.75M | $44.28M | $44.12M | $41.56M | $43.64M | $24.10M | $45.00M | $44.66M | $44.01M | $21.91M | $26.22M | $18.78M | $19.14M | $19.92M | $17.85M | $16.76M | $16.92M | $22.39M | $15.93M | $14.63M | $15.51M | $21.59M |
| High Forecast | $54.17M | $50.77M | $49.70M | $47.46M | $50.46M | $47.86M | $47.63M | $45.03M | $48.11M | $46.11M | $44.19M | $41.56M | $43.64M | $28.92M | $45.64M | $45.96M | $45.29M | $26.29M | $31.46M | $18.97M | $19.33M | $23.90M | $18.03M | $16.93M | $17.09M | $26.87M | $16.09M | $14.78M | $15.67M | $25.91M |
| Low Forecast | $51.36M | $48.14M | $47.13M | $45.00M | $47.84M | $45.38M | $45.16M | $42.70M | $45.62M | $42.95M | $44.01M | $41.56M | $43.64M | $19.28M | $44.40M | $43.58M | $42.95M | $17.53M | $20.97M | $18.63M | $18.99M | $15.93M | $17.71M | $16.63M | $16.78M | $17.91M | $15.80M | $14.52M | $15.39M | $17.27M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.43% | 0.53% | - | - | 0.32% | 0.94% | - | - | 1.64% | 1.54% | - | - | 1.68% | 1.68% | - |
3 analysts predict NEOG's average Quarter EBITDA for Nov 23 to be $45.00M, with a high of $45.64M and a low of $44.40M. This is 135.16% upper than Neogen's previous annual EBITDA (Aug 23) of $19.14M.
Neogen Net Income Forecast
| May 27 | Mar 27 | Nov 26 | Aug 26 | May 26 | Mar 26 | Nov 25 | Aug 25 | May 25 | Mar 25 | Nov 24 | Aug 24 | May 24 | Mar 24 | Nov 23 | Aug 23 | May 23 | Mar 23 | Dec 22 | Aug 22 | May 22 | Mar 22 | Dec 21 | Aug 21 | May 21 | Mar 21 | Dec 20 | Aug 20 | May 20 | Mar 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 3 | 2 | 2 | 1 | 17 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 5 | 5 | 5 | 9 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.50M | $5.57M | - | - | $5.21M | $14.96M | - | - | $17.08M | $15.76M | - | - | $15.86M | $16.35M | - |
| Avg Forecast | $13.01M | $8.67M | $2.17M | $-2.17M | $9.76M | $5.42M | $-2.17M | $-4.34M | $542.03K | $-3.79M | $-2.71M | $-7.23M | $-2.17M | $9.88M | $5.42M | $5.42M | $2.89M | $8.98M | $15.13M | $22.75M | $24.92M | $8.16M | $36.84M | $34.67M | $29.98M | $13.89M | $33.95M | $29.80M | $32.23M | $14.01M |
| High Forecast | $13.50M | $9.00M | $2.25M | $-2.10M | $10.13M | $5.63M | $-2.10M | $-4.20M | $562.62K | $-3.25M | $-2.46M | $-7.00M | $-2.10M | $11.85M | $5.63M | $5.63M | $3.00M | $10.78M | $18.16M | $23.06M | $25.25M | $9.80M | $37.33M | $35.13M | $30.37M | $16.67M | $34.40M | $30.19M | $32.66M | $16.81M |
| Low Forecast | $12.60M | $8.40M | $2.10M | $-2.25M | $9.45M | $5.25M | $-2.25M | $-4.50M | $525.07K | $-4.07M | $-2.81M | $-7.50M | $-2.25M | $7.90M | $5.06M | $5.25M | $2.80M | $7.18M | $12.11M | $22.52M | $24.66M | $6.53M | $36.46M | $34.31M | $29.67M | $11.11M | $33.60M | $29.49M | $31.90M | $11.21M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.28% | 1.93% | - | - | 0.23% | 0.60% | - | - | 0.49% | 0.53% | - | - | 0.53% | 0.51% | - |
Neogen's average Quarter net income forecast for Nov 23 is $5.42M, with a range of $5.06M to $5.63M. NEOG's average Quarter net income forecast represents a 260.63% increase compared to the company's last Quarter net income of $1.50M (Aug 23).
Neogen SG&A Forecast
| May 27 | Mar 27 | Nov 26 | Aug 26 | May 26 | Mar 26 | Nov 25 | Aug 25 | May 25 | Mar 25 | Nov 24 | Aug 24 | May 24 | Mar 24 | Nov 23 | Aug 23 | May 23 | Mar 23 | Dec 22 | Aug 22 | May 22 | Mar 22 | Dec 21 | Aug 21 | May 21 | Mar 21 | Dec 20 | Aug 20 | May 20 | Mar 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 3 | 2 | 2 | 1 | 17 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 5 | 5 | 5 | 9 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $90.90M | $92.70M | - | - | $51.33M | $43.14M | - | - | $33.94M | $33.36M | - | - | $27.53M | $28.33M | - |
| Avg Forecast | $91.87M | $86.10M | $84.30M | $80.48M | $85.58M | $81.17M | $80.78M | $76.37M | $81.60M | $77.29M | $77.02M | $72.54M | $76.18M | $84.35M | $78.55M | $77.96M | $76.82M | $76.68M | $61.21M | $45.20M | $46.07M | $69.71M | $42.98M | $40.36M | $40.73M | $35.14M | $38.35M | $35.23M | $37.35M | $32.68M |
| High Forecast | $94.55M | $88.62M | $86.76M | $82.84M | $88.08M | $83.55M | $83.14M | $78.60M | $83.99M | $80.48M | $77.14M | $72.54M | $76.18M | $101.22M | $79.67M | $80.23M | $79.06M | $92.02M | $73.45M | $45.67M | $46.55M | $83.65M | $43.41M | $40.77M | $41.15M | $42.17M | $38.74M | $35.59M | $37.73M | $39.22M |
| Low Forecast | $89.66M | $84.03M | $82.27M | $78.55M | $83.52M | $79.22M | $78.84M | $74.53M | $79.64M | $74.97M | $76.83M | $72.54M | $76.18M | $67.48M | $77.50M | $76.08M | $74.97M | $61.35M | $48.97M | $44.84M | $45.71M | $55.77M | $42.63M | $40.04M | $40.41M | $28.11M | $38.04M | $34.95M | $37.05M | $26.14M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.17% | 1.21% | - | - | 1.14% | 0.94% | - | - | 0.84% | 0.82% | - | - | 0.78% | 0.76% | - |
Neogen's average Quarter SG&A projection for Nov 23 is $78.55M, based on 3 Wall Street analysts, with a range of $77.50M to $79.67M. The forecast indicates a -13.60% fall compared to NEOG last annual SG&A of $90.90M (Aug 23).
Neogen EPS Forecast
| May 27 | Mar 27 | Nov 26 | Aug 26 | May 26 | Mar 26 | Nov 25 | Aug 25 | May 25 | Mar 25 | Nov 24 | Aug 24 | May 24 | Mar 24 | Nov 23 | Aug 23 | May 23 | Mar 23 | Dec 22 | Aug 22 | May 22 | Mar 22 | Dec 21 | Aug 21 | May 21 | Mar 21 | Dec 20 | Aug 20 | May 20 | Mar 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 3 | 2 | 2 | 1 | 17 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 5 | 5 | 5 | 9 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.03 | - | - | $0.05 | $0.14 | - | - | $0.16 | $0.15 | - | - | $0.15 | $0.15 | - |
| Avg Forecast | $0.06 | $0.04 | $0.01 | $-0.01 | $0.04 | $0.03 | $-0.01 | $-0.02 | - | $-0.02 | $-0.01 | $-0.03 | $-0.01 | $0.01 | $0.03 | $0.03 | $0.01 | $-0.01 | $1.95 | $0.10 | $0.12 | $0.12 | $0.17 | $0.16 | $0.14 | $0.13 | $0.16 | $0.14 | $0.15 | $0.14 |
| High Forecast | $0.06 | $0.04 | $0.01 | $-0.01 | $0.05 | $0.03 | $-0.01 | $-0.02 | - | $-0.01 | $-0.01 | $-0.03 | $-0.01 | $0.02 | $0.03 | $0.03 | $0.01 | $-0.01 | $1.96 | $0.11 | $0.12 | $0.12 | $0.17 | $0.16 | $0.14 | $0.13 | $0.16 | $0.14 | $0.15 | $0.14 |
| Low Forecast | $0.06 | $0.04 | $0.01 | $-0.01 | $0.04 | $0.02 | $-0.01 | $-0.02 | - | $-0.02 | $-0.01 | $-0.03 | $-0.01 | $0.01 | $0.02 | $0.02 | $0.01 | $-0.02 | $1.95 | $0.10 | $0.11 | $0.12 | $0.17 | $0.16 | $0.14 | $0.13 | $0.16 | $0.14 | $0.15 | $0.13 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.94% | - | - | 0.48% | 1.22% | - | - | 0.99% | 1.06% | - | - | 1.09% | 1.03% | - |
According to 2 Wall Street analysts, Neogen's projected average Quarter EPS for Aug 23 is $0.03, with a low estimate of $0.02 and a high estimate of $0.03. This represents a -3.10% decrease compared to NEOG previous annual EPS of $0.03 (May 23).
Neogen Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| ACRS | Aclaris Therapeutics | $2.36 | $6.00 | 154.24% | Buy |
| MYGN | Myriad Genetics | $12.54 | $30.20 | 140.83% | Hold |
| ICLR | ICON Public | $198.12 | $337.00 | 70.10% | Buy |
| NEOG | Neogen | $11.50 | $17.50 | 52.17% | Buy |
| RDNT | RadNet | $67.17 | $89.00 | 32.50% | Buy |
| IQV | IQVIA | $198.07 | $249.63 | 26.03% | Buy |
| XGN | Exagen | $4.07 | $5.00 | 22.85% | Buy |
| SHC | Sotera Health | $13.68 | $16.00 | 16.96% | Buy |
| QGEN | Qiagen | $43.77 | $49.00 | 11.95% | Buy |
| MEDP | Medpace | $343.02 | $369.67 | 7.77% | Hold |